CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity
Robert Fisher(Boston University), Rhoda M. Alani(Boston University), Christina Ennis(Boston University), Jarrod A. Marto(Harvard University), Kwangwoon Lee(Brigham and Women's Hospital), Kihyun Park(Boston University), Eric H. Raabe(Johns Hopkins University), Simone Sidoli(Albert Einstein College of Medicine), Katarina Pinjušić(Harvard University), Stephanie Stransky(Albert Einstein College of Medicine), Chad W. Hicks(Johns Hopkins University), Alexander P. Cole(Brigham and Women's Hospital), Catherine J Wu(Harvard University), Allison P. Vanasse(Dana-Farber Cancer Institute), Derin B. Keskin(Dana-Farber Cancer Institute), Scott Ficcaro(Brigham and Women's Hospital), Anupa Geethadevi(Bloomberg (United States))
Cited by 1
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.4k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
|Nature Biotechnology|2019|539
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
|Cancer Cell|2021|515